rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: LC-MS in Drug Bioanalysis
  name:
    name part: Xu, Q. Alan.
    role:
      role term: editor.
  name:
    name part: Madden, Timothy L.
    role:
      role term: editor.
  name:
    name part: SpringerLink (Online service)
  type of resource: text
  origin info:
    place:
      place term: xxu
    date issued: 2012
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: electronic
    form: electronic resource
    reformatting quality: access
    form: remote
    extent: XII, 472 p. online resource.
  abstract: High performance liquid chromatography – mass spectrometry (LC-MS) combines the separation power of liquid chromatography with the high sensitivity and selectivity of mass spectrometry. Therefore, LC-MS becomes the method of choice for drug bioanalysis in therapeutic drug monitoring, toxicology, and drug discovery and development. LC-MS in Drug Bioanalysis offers discussions on: ● LC-MS/MS method development and validation in a regulated environment ● Internal standard use in LC-MS/MS bioanalysis ● Pitfalls of LC-MS/MS and how to overcome them ● Dried blood spot sampling ● Microflow LC-MS/MS ● LC-MS/MS in therapeutic drug monitoring ● Applications of LC-MS/MS in drug bioanalysis This book will aid readers to improve their skills in LC-MS/MS method development, validation, and applications in the analysis of drugs and their metabolites in complex biological matrices. In addition, this book provides detailed information on the bioanalysis of antidepressants, antipsychotics, steroid hormones, anticancer agents, and drugs of abuse. Newer methodologies are discussed including the use of unique sample preparation techniques and the implementation of imaging mass spectrometry in the localization of drug and drug metabolites in tissues.
  table of contents: Internal standards for quantitative LC-MS bioanalysis -- Method development, validation and sample analysis for regulated quantitative bioanalysis using LC-MS/MS -- Impact of sampling paper/cards on bioanalytical quantitation via dried blood spots by liquid chromatography - mass spectrometry -- Highly sensitive pharmaceutical and clinical analysis using selective solid-phase extraction coupled to microflow liquid chromatography and isotope-dilution mass spectrometry -- Pitfalls of LC-MS/MS in the clinical laboratory -- Therapeutic drug monitoring to support clinical pharmacogenomics -- Liquid chromatography - mass spectrometry for the determination of antidepressants and some of their major metabolites in human biological matrices -- The analysis of antipsychotic drugs in human biosamples by LC-MS -- Therapeutic drug monitoring of targeted anticancer therapy - tyrosine kinase inhibitors and selective oestrogen receptor modulators: a clinical pharmacology laboratory perspective -- Applications of mass spectrometry in analyses of steroid hormones -- Liquid chromatography - mass spectrometric analysis of tropane alkaloids in mammalian samples: techniques and applications -- Analysis of illicit drugs in human biological samples by LC-MSn -- Use of matrix assisted laser desorption/ionization imaging mass spectrometry (MALDI-IMS) in the development of novel small molecule drugs -- A planar integrated micro mass spectrometer.
  note: edited by Q. Alan Xu, Timothy L. Madden.
  subject:
    topic: Chemistry
  subject:
    topic: Pharmacology
  subject:
    topic: Analytical chemistry
  subject:
    topic: Mass spectrometry
  subject:
    topic: Chromatography
  subject:
    topic: Chemistry
  subject:
    topic: Mass Spectrometry
  subject:
    topic: Analytical Chemistry
  subject:
    topic: Pharmacology/Toxicology
  subject:
    topic: Chromatography
  classification: QD96.M3
  classification: 543.65
  related item:
    title info:
      title: Springer eBooks
  identifier: 9781461438281
  identifier: http://dx.doi.org/10.1007/978-1-4614-3828-1
  record info:
    record creation date: 120713
    record change date: 20151028121630.0
    record identifier: 978-1-4614-3828-1